NCT01906866 2024-04-23Efficacy and Safety of CircadinĀ® in the Treatment of Sleep Disturbances in Children With Neurodevelopment DisabilitiesNeurim Pharmaceuticals Ltd.Phase 3 Completed125 enrolled 22 charts
NCT01030939 2017-06-20Study to Investigate Safety, Tolerability, Pharmacokinetics and Cardiac Function After Repeat Doses of SB-649868 in Healthy-volunteersGlaxoSmithKlinePhase 1 Completed72 enrolled